Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer

AIMS: To determine whether IHC4 score assessed on pre-treatment core biopsies (i) predicts response to neo-adjuvant chemotherapy in ER-positive (ER+) breast cancer; (ii) provides more predictive information than Ki67 alone. METHODS: 113 patients with ER+ primary breast cancer treated with neo-adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheri, A., Smith, I. E., Hills, M., Jones, R. L., Johnston, S. R., Dowsett, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487724/
https://www.ncbi.nlm.nih.gov/pubmed/28447240
http://dx.doi.org/10.1007/s10549-017-4266-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487724/
https://www.ncbi.nlm.nih.gov/pubmed/28447240
http://dx.doi.org/10.1007/s10549-017-4266-9

Ejemplares similares